Sharemaestro company-news research for Cizzle Biotechnology Holdings Plc (CIZ), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
LSE
United Kingdom
Provisional evidence
Company news sentiment
CIZ news sentiment
Cizzle Biotechnology Holdings Plc
Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.
30-day score50Neutral is 50
Early balanced news score
14/100 evidence confidence
100% direct company focus
3 current stories across 2 publishers
Current company news
Early balanced news score
3 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.
Observed headline tone50/100
→
Reliability-adjusted score50/100
Latest source headline
Cizzle Biotechnology’s Lung Cancer Blood Test Enters Full Commercial Sales in Key Texas Markets
TipRanks · 30 Jul 2026 20:10 · Source lookup
Freshness, source quality and evidence depth temper uncertain readings toward 50; confidence remains a separate reliability measure.
What supports the score
3 current stories are mapped specifically to CIZ.
What limits the score
Only 2 publishers currently contribute to the measured read.
The stories agree, but freshness-weighted evidence is only 0.003.
Evidence confidence is 14/100, below the threshold for a firm classification.
50/100
News scoreEarly balanced news score
14/100
Confidencethin evidence
100%/100
Company news3 company stories
100/100
Story agreement0/100 difference
News history
Daily score and story count over 30 days
15 Jul30 Jul13 Aug
News scoreStory count50 baseline
Confidence
How reliable the score is
Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.
Amount of evidence0
0.003 after freshness weightingSource breadth40
2 independent publishersCompany relevance100
share tied directly to this companyFreshness3
recency-weighted evidenceAgreement100
how closely stories agreePublisher mix30
less reliance on one publisherPrice and news history
News score and weekly price over 26 weeks
Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.
One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
WeekNews scoreCloseWeekly move
07 Aug 202650GBP 0.02-8.1%
31 Jul 202650GBP 0.02-9.8%
24 Jul 202650GBP 0.02+3.8%
17 Jul 202650GBP 0.02-16.0%
10 Jul 202650GBP 0.02-6.0%
03 Jul 202650GBP 0.03+4.2%
26 Jun 202650GBP 0.02-14.3%
Provisional evidence
News subjects
What is shaping the score
Market update502 stories · 67%
Earnings501 stories · 33%
Source mix
Where the evidence comes from
TipRanks502 stories · 67%
Market source501 stories · 33%
Recurring subjects
Subjects appearing most often
Topic structure will appear when classified tags are present in the current feed.
Earlier readings
How the score has changed
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
25 Jun50 neutral13 Aug 16:00
ConstructiveBalanced or withheldCautious
Changes in the stored score
Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.
| Observed | Score | Move | Confidence | Stories | Status |
|---|---|---|---|---|---|
| 13 Aug 16:00 | 50 | +0 | 14/100 (-12) | 3 (-2) | Provisional |
| 30 Jul 23:59 | 50 | +0 | 26/100 (0) | 5 (-1) | Provisional |
| 19 Jul 23:59 | 50 | +0 | 26/100 (+2) | 6 (+1) | Provisional |
| 15 Jul 23:59 | 50 | -1 | 24/100 (-3) | 5 (+1) | Provisional |
| 11 Jul 23:59 | 51 | +1 | 27/100 (-2) | 4 (+1) | Provisional |
| 07 Jul 23:59 | 50 | +0 | 29/100 (+4) | 3 (+1) | Provisional |
| 26 Jun 23:59 | 50 | +0 | 25/100 (0) | 2 (+1) | Provisional |
| 25 Jun 23:59 | 50 | Start | 25/100 | 1 | Provisional |
Source headlines
The news behind the score
Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.
#150Tone
TipRanksDirect company coverageScored from headlineSource lookup
Cizzle Biotechnology’s Lung Cancer Blood Test Enters Full Commercial Sales in Key Texas Markets
- Published
- 30 Jul 2026 20:10
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- Medium · 18% · 13.8d old
- Duplicates
- 1 consolidated
#250Tone
Market sourceDirect company coverageScored from headlineSource lookup
Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks
- Published
- 19 Jul 2026 16:13
- News subject
- Earnings
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- High · 81.9% · 25.0d old
- Duplicates
- 1 consolidated
#350Tone
TipRanksDirect company coverageScored from headlineSource lookup
Cizzle Biotechnology Enters Commercial Phase With U.S. Lung Cancer Test Accreditation
- Published
- 15 Jul 2026 10:35
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- Low · <0.1% · 29.2d old
- Duplicates
- 1 consolidated
Earlier company news
CIZ news archive
Stored newest first for historical research. These older headlines are retained for reference and do not contribute to the current sentiment gauge above. Where an early legacy import did not retain its canonical URL, the headline links to an exact publisher-aware source lookup instead of inventing an article address.
Jul
11
2026
StocktwitsArchivedLegacy headline · tone unscoredLegacy source lookup
Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?
- Published
- 11 Jul 2026 18:43
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
07
2026
TradingViewArchivedLegacy headline · tone unscoredLegacy source lookup
Price to earnings forward of Cizzle Biotechnology Holdings PLC – LSE:CIZ
- Published
- 7 Jul 2026 17:32
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
26
2026
TradingViewArchivedLegacy headline · tone unscoredLegacy source lookup
Cizzle Biotechnology Holdings PLC Actuals & Estimates (LSE:CIZ)
- Published
- 26 Jun 2026 11:19
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
25
2026
Yorkshire PostArchivedLegacy headline · tone unscoredLegacy source lookup
Cizzle Biotechnology: York firm sees early stage lung cancer test accredited in US
- Published
- 25 Jun 2026 04:25
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
How the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
It measures news already published. It is not a forecast, recommendation or price target.